LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology

    08/05/2026

    PRESS RELEASE

    Brussels, 8 May 2026 – EuropaBio is happy to welcome its newest member, Technovative Solutions Ltd.

    Founded in 2012, Technovative Solutions Ltd. is a a UK-based SME, based in Manchester. It operates at the intersection of biotechnology, materials innovation, and artificial intelligence within the life sciences and pharmaceutical sectors. The company focuses on developing advanced digital solutions, including an AI-based foundation model designed to accelerate material discovery and optimisation. Alongside this, Technovative Solutions Ltd. is advancing material innovations grounded in eco-design principles, with a strong emphasis on sustainability.

    The company’s technologies aim to enhance traceability, transparency, and regulatory compliance across the pharmaceutical value chain, while enabling more efficient and sustainable approaches to material innovation. By combining AI, materials science, and biotech applications, Technovative Solutions Ltd. is building capabilities in areas such as sustainable biomaterials and digitally enabled R&D, working collaboratively with partners across the life sciences ecosystem.

    By joining EuropaBio, Technovative Solutions Ltd. seeks to engage actively with Europe’s leading biotechnology community, contribute to policy and regulatory discussions, and stay aligned with scientific and technological developments. As an SME, the company is particularly interested in collaboration opportunities, knowledge exchange, and initiatives that support innovation, sustainability, and growth within European biotech.

    Dr. Claire Skentelbery, Director General of EuropaBio, commented: “Technovative Solutions is the perfect representation of how small innovators create the interface between different technologies, vital for Europe’s translation of science into impact. We are delighted to welcome Fahim and the team to EuropaBio and look forward to learning from them.”

    Dr. Fahim Chowdhury, CEO at Technovative Solutions Ltd., added: “We are thrilled to become part of EuropaBio’s vibrant community. Technovative Solutions Ltd is committed to accelerating AI‑driven, sustainable solution development, and we look forward to working with partners across Europe to turn cutting‑edge science into real‑world impact.”

    Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    29/05/2026

    The Luxembourg Institute of Science and Technology joins EuropaBio: Advancing Applied Biotechnology in Europe


    Read more
    26/05/2026

    EuropaBio Position on the Food and Feed SafetyOmnibus (May 2026)


    Read more
    18/05/2026

    Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force


    Read more

    Important links

    • The Luxembourg Institute of Science and Technology joins EuropaBio: Advancing Applied Biotechnology in Europe
    • EuropaBio Position on the Food and Feed SafetyOmnibus (May 2026)

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.